We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
The Brucella Reference Unit (BRU) provides laboratory diagnostic and clinical management services for Brucella species.
The characteristics, diagnosis and management of Candida auris (C. auris).
Sets out COVID-19 testing for hospice patients and staff.
How to confirm a measles diagnosis, manage cases and contacts, control infection, and vaccinate young or partially-covered patients.
How to spot dourine, what to do if you suspect it and measures to prevent its spread.
FCDO travel advice for Brazil. Includes safety and security, insurance, entry requirements and legal differences.
Background information and advice on coronavirus (COVID-19) for health and care professionals.
The surveillance, epidemiology, diagnosis and management of gonorrhoea (Neisseria gonorrhoeae).
Advice and guidance on the health needs of migrant patients for healthcare practitioners.
Comply with good pharmacovigilance practice and prepare for an inspection.
The Medicines and Healthcare products Regulatory Agency (MHRA) has today (7 March 2024) approved the medicine ganaxolone (Ztalmy) as the first anti-seizure medication in the UK to treat cyclin-dependent kinase-like 5 (CDKL5) deficiency disorder (CDD).
Apply for an import certificate to import a medicinal product into the UK for veterinary use.
Work out the VAT liability of goods and services supplied by health and care institutions and providers of non residential care to children.
Advice and guidance on the health needs of migrant patients from Mexico for healthcare practitioners.
The Medicines and Healthcare products Regulatory Agency (MHRA) has today (6 March 2024) approved the medicine piflufolastat (18F) (Pylclari) as a diagnostic tool for people with suspected or known prostate cancer.
Advice and guidance on the health needs of migrant patients from Ghana for healthcare practitioners.
The symptoms and epidemiology of botulism.
Find out about the symptoms of COVID-19, what to do if you or your child has them and when to get medical help.
Advice and guidance on the health needs of migrant patients from Djibouti for healthcare practitioners.
Find out about local procedures, burials and cremations, and returning the body to the UK.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.